| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/05/2006 | US20060003939 Stimulating or accelerating apoptosis by contacting cell with an (Inhibitor of Apoptosis Protein) IAPi-derived peptide having a Trp-box consensus sequence and an RHG amino acid consensus sequence; antitumor, anticarcinogenic and antiinflammatory agents; induces self-ubiquitination; drug screening |
| 01/05/2006 | US20060003938 Novel pyrrhocoricin-derived peptides and methods of use thereof |
| 01/05/2006 | US20060003937 Urocortin-III and uses thereof |
| 01/05/2006 | US20060003936 Method for modulating the production of a selected protein in vivo |
| 01/05/2006 | US20060003935 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/05/2006 | US20060003934 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 01/05/2006 | US20060003931 Crystal structure of the hepatocyte growth factor and methods of use |
| 01/05/2006 | US20060003930 CD39/ecto-adpase for treatment of thrombotic and ischemic disorders |
| 01/05/2006 | US20060003929 variants or fragments of the Drosophilia sog proteins, used in the therapy of alopecia, cancers or neurodegenerative disorders |
| 01/05/2006 | US20060003928 Use of osteoprotegerin for the treatment and/or prevention of fibrotic disease |
| 01/05/2006 | US20060003924 Sulfation-independent L-selectin or E-selectin ligand (HCELL) and therapeutics thereof |
| 01/05/2006 | US20060003918 Prolonged delivery of peptides |
| 01/05/2006 | US20060003915 Means and methods for the specific modulation of target genes in the cns and the eye and methods for their identification |
| 01/05/2006 | US20060003453 High-efficiency AAV helper functions |
| 01/05/2006 | US20060003451 Cell lines and constructs useful in production of E1-deleted adenoviruses in absence of replication competent adenovirus |
| 01/05/2006 | US20060003420 Monomeric and dimeric fluorescent protein variants and methods for making same |
| 01/05/2006 | US20060003419 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/05/2006 | US20060003418 Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
| 01/05/2006 | US20060003417 Polypeptide; polyethylene glycolylated polypeptide; antidiabetic agents; side effect reduction |
| 01/05/2006 | US20060003409 Novel molecules of the card-related protein family and uses thereof |
| 01/05/2006 | US20060003407 Methods for preparing highly active april ligand polypeptides |
| 01/05/2006 | US20060003401 Method for preparing a water-soluble carbon nanotube wrapped with self-assembly materials |
| 01/05/2006 | US20060003393 Pathogenicity determinants which can be used as targets for developing means for preventing and controlling bacterial infections and/or systemic dissemination |
| 01/05/2006 | US20060003387 Cell display libraries |
| 01/05/2006 | US20060003380 Human tumor necrosis factor receptor TR-17 |
| 01/05/2006 | US20060003379 Smad6 and uses thereof |
| 01/05/2006 | US20060003378 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics |
| 01/05/2006 | US20060003377 Therapeutic and diagnostic proteins comprising a SOCS box |
| 01/05/2006 | US20060003375 Novel polypeptide - human retinoic acid-responsive protein 53.57 and a polynucleotide encoding the same |
| 01/05/2006 | US20060003370 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/05/2006 | US20060003367 Polynucleotides encoding a novel human Kupffer cell receptor protein, BGS-18 |
| 01/05/2006 | US20060003358 Polymorphic kinase anchor proteins and nucleic acids encoding the same |
| 01/05/2006 | US20060003355 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/05/2006 | US20060003349 Tm leveling compositions |
| 01/05/2006 | US20060003341 Cloned genes encoding reverse transcriptase lacking RNase H activity |
| 01/05/2006 | US20060003334 Protein (poly)peptides libraries |
| 01/05/2006 | US20060003332 Method for multiplex PNA-FISH |
| 01/05/2006 | US20060003330 Streptococcus pneumoniae pbp2x mini-protein and uses thereof |
| 01/05/2006 | US20060003316 Immunogenic compositions derived from poxviruses and methods of using same |
| 01/05/2006 | US20060003315 Membrane-anchored beta2 microglobulin covalently linked to mhc class 1 peptide epitopes |
| 01/05/2006 | US20060003073 adsorption of whey proteins onto ion exchange resins, then desorbing by flowing bufferd solutions and collecting the desorbed nondenatured whey proteins, having low turbidity in solution across a wide range of pH values including their isoelectric points |
| 01/05/2006 | US20060002993 Genetic engineered protein; transgenic animal, used to elicit a humoral or cellular immune response |
| 01/05/2006 | US20060002961 Immunogens; Streptococcus pneumoniae polysaccharide-protein conjugate/antigen, and adjuvant which induces (cytotoxic T) lymphocytes |
| 01/05/2006 | US20060002958 Attenuation of metapneumovirus |
| 01/05/2006 | US20060002957 Method and device for detecting feline immunodeficiency virus |
| 01/05/2006 | US20060002953 Molecular differences between species of the M. tuberculosis complex |
| 01/05/2006 | US20060002952 Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
| 01/05/2006 | US20060002951 Inhibition of the tRNALys3-primed initiation of reverse transcription in HIV-1 by APOBEC3G |
| 01/05/2006 | US20060002950 Immunomodulatory protein derived from Trypanosomes and uses thereof |
| 01/05/2006 | US20060002948 Polypeptide isolated from Dermatophagoides; use of polypeptides, polynucleotides and/or antibodies in therapy and diagnosis of allergic disorders; genetic engineering |
| 01/05/2006 | US20060002947 Ii-key/antigenic epitope hybrid peptide vaccines |
| 01/05/2006 | US20060002946 Targeted immunogens |
| 01/05/2006 | US20060002939 Monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal; light and heavy chains comprising complementarity determining regions |
| 01/05/2006 | US20060002934 Egf receptor antagonists in the treatment of gastric cancer |
| 01/05/2006 | US20060002926 isolated and/or recombinant; characterized by high affinity binding of one or more chemokines, such as eotaxin, RANTES and/or MCP-3, and/or the ability to stimulate a (one or more) cellular response(s) (e.g., chemotaxis, exocytosis, release of one or more inflammatory mediators) |
| 01/05/2006 | US20060002925 Soluble ZcytoR14, anti-ZcytoR14 antibodies and binding partners and methods of using in inflammation |
| 01/05/2006 | US20060002923 Recombinant anti-osteopontin antibody and use thereof |
| 01/05/2006 | US20060002919 15625 receptor, a novel G-protein coupled receptor |
| 01/05/2006 | US20060002905 Mutant forms of EtxB and CtxB and their use as carriers |
| 01/05/2006 | US20060002904 Receptor and related products and methods |
| 01/05/2006 | US20060002895 Induction of apoptic or cytotoxic gene expression by adenoviral mediated gene codelivery |
| 01/05/2006 | US20060002893 Targeted adenovirus vectors for delivery of heterologous genes |
| 01/05/2006 | DE19903125B4 Verfahren zur Trocknung von Kristallen von Insulin oder Insulinanaloga A process for the drying of crystals of insulin or insulin analogs |
| 01/05/2006 | DE10226674B4 Verfahren zur Testung des hormonellen Effekts von Substanzen Method for testing the hormonal effect of substances |
| 01/05/2006 | DE102004029470A1 Verfahren zur Bestimmung von Aggrekanase-Aktivitäten Method for determination of aggrecanase activity |
| 01/05/2006 | DE102004028778A1 An oligopeptide, useful for controlling the biological activity of cellular biomolecules, comprising at least one cysteine residue and two alpha helical zones |
| 01/05/2006 | DE102004027816A1 Verfahren zur Reinigung von Erythropoietin A process for the purification of erythropoietin |
| 01/05/2006 | DE102004026135A1 An MHC-Moleküle bindende Tumor-assoziierte Peptide Binding to MHC molecules tumor-associated peptides |
| 01/05/2006 | CA2572015A1 Fc-interferon-beta fusion proteins |
| 01/05/2006 | CA2571781A1 Chimeric proteins and uses thereof |
| 01/05/2006 | CA2571420A1 Metastin derivatives and use thereof |
| 01/05/2006 | CA2571350A1 Peptides for inhibiting the interaction of protein kinase a and protein kinase a anchor proteins |
| 01/05/2006 | CA2558760A1 Chimeric human growth hormone derived from the placenta and pituitary isoform and processes for obtaining said chimera |
| 01/04/2006 | EP1612555A1 Cryptic peptides for use in inducing immunologic tolerance |
| 01/04/2006 | EP1612280A2 Diagnosis and treatment of Williams syndrome |
| 01/04/2006 | EP1612272A2 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 01/04/2006 | EP1612270A2 Rétroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
| 01/04/2006 | EP1612268A1 Receptor ligand VEGF-C |
| 01/04/2006 | EP1612263A1 PTH receptor and screening assay utilizing the same |
| 01/04/2006 | EP1612223A2 Polypeptides with FC binding ability |
| 01/04/2006 | EP1612222A2 Olfactory and pheromones G-protein coupled receptors |
| 01/04/2006 | EP1612221A2 Receptor-based interaction trap |
| 01/04/2006 | EP1612220A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/04/2006 | EP1612219A1 Allergen from house-dust mites |
| 01/04/2006 | EP1612218A1 Surface protein of Neisseria bacteria |
| 01/04/2006 | EP1612217A2 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 01/04/2006 | EP1611900A1 Method of treating inflammtory disease associated with bone destruction |
| 01/04/2006 | EP1611240A2 Interacts with ice1 and regulates cbf expression and freezing tolerance in arabidopsis |
| 01/04/2006 | EP1611239A1 Cyclic amp response element activator proteins and uses related thereto |
| 01/04/2006 | EP1611238A2 Glutamate transport modulatory compounds and methods |
| 01/04/2006 | EP1611237A1 Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby |
| 01/04/2006 | EP1611153A2 Antitumor effect of mutant bik |
| 01/04/2006 | EP1611152A2 Adp-ribosylating toxin from listeria monocytogenes |
| 01/04/2006 | EP1611093A2 Modified transferrin fusion proteins |
| 01/04/2006 | EP1610825A2 Methods for rational pegylation of proteins |
| 01/04/2006 | EP1610824A2 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 01/04/2006 | EP1610817A2 Infectious bronchitis virus with an altered spike gene |
| 01/04/2006 | EP1610816A2 Mva virus expressing modified hiv envelope, gag, and pol genes |
| 01/04/2006 | EP1610813A1 CONFORMATIONALLY CONSTRAINED PARATHYROID HORMONES WITH a-HELIX STABILIZERS |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |